First Horizon’s Triglide Could Have Compliance Benefit Over Other Fenofibrate Products
This article was originally published in The Pink Sheet Daily
Executive Summary
The novel fenofibrate formulation uses SkyePharma’s solubilization technology. First Horizon sees a fit with its existing cardiovascular products Altoprev and Fortamet.